Estrella Immunopharma Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 05/15/2026 | 4.10 M | $4.34 M | 100.00% | 9.73% |
| 05/15/2026 | 382.47 K | $405.42 K | 100.00% | 0.91% | |
| WELLS FARGO & COMPANY/MN | 05/11/2026 | 264.39 K | $280.25 K | 100.00% | 0.63% |
| GEODE CAPITAL MANAGEMENT, LLC | 05/15/2026 | 157.49 K | $166.93 K | 43.42% | 0.37% |
| VANGUARD FIDUCIARY TRUST CO | 05/08/2026 | 64.92 K | $68.82 K | 100.00% | 0.15% |
| RENAISSANCE TECHNOLOGIES LLC | 05/14/2026 | 62.80 K | $66.56 K | -48.73% | 0.15% |
| STATE STREET CORP | 05/15/2026 | 43.25 K | $45.85 K | 0.00% | 0.10% |
| BLACKROCK, INC. | 05/13/2026 | 39.89 K | $42.28 K | 50.70% | 0.09% |
| NORTHERN TRUST CORP | 05/14/2026 | 19.62 K | $20.80 K | 0.00% | 0.05% |
| US BANCORP \DE\ | 05/15/2026 | 16.90 K | $17.92 K | 100.00% | 0.04% |
| UBS GROUP AG | 05/05/2026 | 15.08 K | $15.98 K | 373.14% | 0.04% |
| ROYAL BANK OF CANADA | 05/15/2026 | 6.60 K | $7.00 K | 0.00% | 0.02% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 05/15/2026 | 4.86 K | $5.15 K | 100.00% | 0.01% |
| TORONTO DOMINION BANK | 05/15/2026 | 1.09 K | $1.15 K | 100.00% | 0.00% |
| WOLVERINE ASSET MANAGEMENT LLC | 05/04/2026 | 468 | $496 | 100.00% | 0.00% |
| MORGAN STANLEY | 05/15/2026 | 1 | $1 | -99.99% | 0.00% |
| BANK OF AMERICA CORP /DE/ | 05/18/2026 | 0 | $0 | -100.00% | 0.00% |
| MARSHALL WACE, LLP | 05/15/2026 | 0 | $0 | -100.00% | 0.00% |
| CITADEL ADVISORS LLC | 05/15/2026 | 0 | $0 | -100.00% | 0.00% |
| JANE STREET GROUP, LLC | 05/12/2026 | 0 | $0 | -100.00% | 0.00% |
| QUADRATURE CAPITAL LTD | 05/15/2026 | 0 | $0 | -100.00% | 0.00% |
| XTX TOPCO LTD | 05/15/2026 | 0 | $0 | -100.00% | 0.00% |
Estrella Immunopharma Inc institutional Ownership - FAQ's
During the previous two years, 25 institutional investors and hedge funds held shares of Estrella Immunopharma Inc. The most heavily invested institutionals were:
ARMISTICE CAPITAL, LLC: 4.1 M
WELLS FARGO & COMPANY/MN: 264,388
GEODE CAPITAL MANAGEMENT, LLC: 157,485
VANGUARD FIDUCIARY TRUST CO: 64,921
RENAISSANCE TECHNOLOGIES LLC: 62,795
STATE STREET CORP: 43,252
12.30% of Estrella Immunopharma Inc stock is owned by institutional investors.
Institutional investors have bought a total of 5.30 M shares in the last 24 months. This purchase volume represents approximately $5.94 M in transactions.